These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27543900)

  • 1. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
    Chakravarty T; Makkar RR; Ascheim DD; Traverse JH; Schatz R; DeMaria A; Francis GS; Povsic TJ; Smith RR; Lima JA; Pogoda JM; Marbán L; Henry TD
    Cell Transplant; 2017 Feb; 26(2):205-214. PubMed ID: 27543900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
    Makkar RR; Kereiakes DJ; Aguirre F; Kowalchuk G; Chakravarty T; Malliaras K; Francis GS; Povsic TJ; Schatz R; Traverse JH; Pogoda JM; Smith RR; Marbán L; Ascheim DD; Ostovaneh MR; Lima JAC; DeMaria A; Marbán E; Henry TD
    Eur Heart J; 2020 Sep; 41(36):3451-3458. PubMed ID: 32749459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).
    Malliaras K; Makkar RR; Smith RR; Cheng K; Wu E; Bonow RO; Marbán L; Mendizabal A; Cingolani E; Johnston PV; Gerstenblith G; Schuleri KH; Lardo AC; Marbán E
    J Am Coll Cardiol; 2014 Jan; 63(2):110-22. PubMed ID: 24036024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
    Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F
    Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.
    Makkar RR; Smith RR; Cheng K; Malliaras K; Thomson LE; Berman D; Czer LS; Marbán L; Mendizabal A; Johnston PV; Russell SD; Schuleri KH; Lardo AC; Gerstenblith G; Marbán E
    Lancet; 2012 Mar; 379(9819):895-904. PubMed ID: 22336189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial.
    Ostovaneh MR; Makkar RR; Ambale-Venkatesh B; Ascheim D; Chakravarty T; Henry TD; Kowalchuk G; Aguirre FV; Kereiakes DJ; Povsic TJ; Schatz R; Traverse JH; Pogoda J; Smith RD; Marbán L; Marbán E; Lima JAC
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34233913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
    Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
    Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy.
    Johnston PV; Sasano T; Mills K; Evers R; Lee ST; Smith RR; Lardo AC; Lai S; Steenbergen C; Gerstenblith G; Lange R; Marbán E
    Circulation; 2009 Sep; 120(12):1075-83, 7 p following 1083. PubMed ID: 19738142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction.
    Reich H; Tseliou E; de Couto G; Angert D; Valle J; Kubota Y; Luthringer D; Mirocha J; Sun B; Smith RR; Marbán L; Marbán E
    J Heart Lung Transplant; 2016 Nov; 35(11):1348-1357. PubMed ID: 27342903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair.
    Cheng K; Malliaras K; Smith RR; Shen D; Sun B; Blusztajn A; Xie Y; Ibrahim A; Aminzadeh MA; Liu W; Li TS; De Robertis MA; Marbán L; Czer LSC; Trento A; Marbán E
    JACC Heart Fail; 2014 Feb; 2(1):49-61. PubMed ID: 24511463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic cardiosphere-derived cells for myocardial regeneration: current progress and recent results.
    Kapelios CJ; Nanas JN; Malliaras K
    Future Cardiol; 2016 Jan; 12(1):87-100. PubMed ID: 26696563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction.
    Malliaras K; Smith RR; Kanazawa H; Yee K; Seinfeld J; Tseliou E; Dawkins JF; Kreke M; Cheng K; Luthringer D; Ho CS; Blusztajn A; Valle I; Chowdhury S; Makkar RR; Dharmakumar R; Li D; Marbán L; Marbán E
    Circulation; 2013 Dec; 128(25):2764-75. PubMed ID: 24061088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
    Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology.
    Tseliou E; Kanazawa H; Dawkins J; Gallet R; Kreke M; Smith R; Middleton R; Valle J; Marbán L; Kar S; Makkar R; Marbán E
    PLoS One; 2016; 11(1):e0144523. PubMed ID: 26784932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction.
    Gallet R; Tseliou E; Dawkins J; Middleton R; Valle J; Angert D; Reich H; Luthringer D; Kreke M; Smith R; Marbán L; Marbán E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25953823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction.
    Lee ST; White AJ; Matsushita S; Malliaras K; Steenbergen C; Zhang Y; Li TS; Terrovitis J; Yee K; Simsir S; Makkar R; Marbán E
    J Am Coll Cardiol; 2011 Jan; 57(4):455-65. PubMed ID: 21251587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction.
    Kanazawa H; Tseliou E; Malliaras K; Yee K; Dawkins JF; De Couto G; Smith RR; Kreke M; Seinfeld J; Middleton RC; Gallet R; Cheng K; Luthringer D; Valle I; Chowdhury S; Fukuda K; Makkar RR; Marbán L; Marbán E
    Circ Heart Fail; 2015 Mar; 8(2):322-32. PubMed ID: 25587096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
    Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
    Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.
    Smith RR; Barile L; Cho HC; Leppo MK; Hare JM; Messina E; Giacomello A; Abraham MR; Marbán E
    Circulation; 2007 Feb; 115(7):896-908. PubMed ID: 17283259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
    Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
    Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.